zoliflodacin (ETX0914)

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

urogenital oe rectal gonorrhea

Contraindications

only 50-80% effective for treatment of pharyngeal gonorrhea

Dosage

single oral dose 2-3 g of zoliflodacin

Adverse effects

gastrointestinal events

Mechanism of action

DNA gyrase/topoisomerase inhibitor

More general terms

References

↑ Taylor SN et al. Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea. N Engl J Med 2018 Nov 8; 379:1835. https://www.nejm.org/doi/10.1056/NEJMoa1706988

Database

PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=76685216

Retrieved from "https://aaushi.info/w/index.php?title=A55513&oldid=952902"

↑ Back to top